Literature DB >> 15389552

Hepatitis C virus replication in stably transfected HepG2 cells promotes hepatocellular growth and tumorigenesis.

Bill S Sun1, Jingbo Pan, Marcy M Clayton, Jie Liu, Xiaoping Yan, Alexey A Matskevich, David S Strayer, Michael Gerber, Mark A Feitelson.   

Abstract

HepG2 cells stably transfected with a full-length, infectious hepatitis C virus (HCV) cDNA demonstrated consistent replication of HCV for more than 3 years. Intracellular minus strand HCV RNA was present. Minus strand synthesis was NS5B dependent, and was sensitive to interferon alpha (IFN alpha) treatment. NS5B and HCV core protein were detectable. HCV stimulated HepG2 cell growth and survival in culture, in soft agar, and accelerated tumor growth in SCID mice. These mice became HCV RNA positive in blood, where the virus was also sensitive to IFN alpha. The RNA banded at the density of HCV, and was resistant to RNase prior to extraction. Hence, HCV stably replicates in HepG2 cells, stimulates hepatocellular growth and tumorigenesis, and is susceptible to IFN alpha both in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15389552     DOI: 10.1002/jcp.20083

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  9 in total

1.  Inhibition effect of Chinese herbal medicine on transcription of hepatitis C virus structural gene in vitro.

Authors:  Jun Dou; Qian Chen; Jing Wang
Journal:  World J Gastroenterol       Date:  2005-06-21       Impact factor: 5.742

Review 2.  Smad3 phospho-isoform signaling in hepatitis C virus-related chronic liver diseases.

Authors:  Takashi Yamaguchi; Katsunori Yoshida; Miki Murata; Koichi Matsuzaki
Journal:  World J Gastroenterol       Date:  2014-09-21       Impact factor: 5.742

Review 3.  Oxidative stress and hepatic Nox proteins in chronic hepatitis C and hepatocellular carcinoma.

Authors:  Jinah Choi; Nicole L B Corder; Bhargav Koduru; Yiyan Wang
Journal:  Free Radic Biol Med       Date:  2014-05-06       Impact factor: 7.376

Review 4.  Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma.

Authors:  Alla Arzumanyan; Helena M G P V Reis; Mark A Feitelson
Journal:  Nat Rev Cancer       Date:  2013-02       Impact factor: 60.716

5.  Hepatitis C virus targets over-expression of arginase I in hepatocarcinogenesis.

Authors:  Wenjun Cao; Bill Sun; Mark A Feitelson; Tong Wu; Ran Tur-Kaspa; Qishi Fan
Journal:  Int J Cancer       Date:  2009-06-15       Impact factor: 7.396

Review 6.  Effects of antiviral therapy on preventing liver tumorigenesis and hepatocellular carcinoma recurrence.

Authors:  Zhong-Ming Tan; Bei-Cheng Sun
Journal:  World J Gastroenterol       Date:  2013-12-21       Impact factor: 5.742

Review 7.  Role of Gut Microbiota in Hepatocarcinogenesis.

Authors:  Haripriya Gupta; Gi Soo Youn; Min Jea Shin; Ki Tae Suk
Journal:  Microorganisms       Date:  2019-05-05

8.  Hepatitis c virus genotype 4 replication in the hepatocellular carcinoma cell line HepG2/C3A.

Authors:  Medhat K Shier; Mohammad S El-Wetidy; Hebatallah H Ali; Mohammad M Al-Qattan
Journal:  Saudi J Gastroenterol       Date:  2016 May-Jun       Impact factor: 2.485

Review 9.  Epigenetic Mechanisms Involved in HCV-Induced Hepatocellular Carcinoma (HCC).

Authors:  Pin Zhao; Samiullah Malik; Shaojun Xing
Journal:  Front Oncol       Date:  2021-07-15       Impact factor: 6.244

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.